Blox Labs Inc. (CSE:BLOX,FWB:BR1B) , a technology development company focused on creating best-in-class software solutions driven by emerging trends in Blockchain, Smart Contracts and Decentralized Applications is pleased to announce the appointment of Mr. Curtis Ingleton as Chief Technology Officer (CTO), effective immediately.

Curtis is currently a technology developer and lead researcher who has guided several companies. He couples 20 years of computer networking experience with nearly a decade of work in Additive Manufacturing (AM) Technology, Applied Robotics and 3D Printing. With these skillsets he founded Genius IE: an engineering consortium focused on Additive Manufacturing Technology. Curtis conducts his research in cooperation with both industry and academia to create future materials, processes and equipment. His services have been sought out by General Motors, Magna Corporation and Clik-Clik to name a few. Product development, process and equipment design are all experiential strengths Curtis draws on. He has been awarded Make Magazine’s Worlds’ Best 3D Printer, Southern Ontario’s Top 40 Under 40 Business People and has received a nomination for a McMaster University Honorary Degree. Curtis brings the resources of a prototyping lab to any company he works with, accelerating their response to market demands and allowing them to deploy sensible solutions for their clients while producing impactful software solutions for the projects he has been involved with. Recently, he has begun plans to standardize the way the industry configures, maintains and manages crypto-mines. He is in the forefront of discussion groups and panels that are pushing forward the evolution of Blockchain Smart Contracts, Decentralized Applications (DApps), and Decentralized Autonomous Organizations (DAO’s).


“We are privileged to welcome someone with Mr. Ingleton’s robust skillset to our team”, commented Jeff Zanini, CEO of BLOX. He continued, “As we continue to build our client roster and execute upon both existing and new projects alike, the technical expertise that Curtis provides will be invaluable. As we are continuously engaged in new project discussions in the evolving Blockchain space, it is imperative that we have a dynamic management team driving the business forward with a wealth of industry contacts on a global front, which is what we have in Curtis and our existing Board”.

In addition to spearheading technology projects, Mr. Ingleton will also be guiding the formation of an Advisory Board. Curtis will report directly to the CEO, Mr. Jeff Zanini.

About Blox Labs

Blox Labs Inc. is a technology development company focused on creating best-in-class software solutions driven by emerging trends in Blockchain, Smart Contracts and Decentralized Applications. BLOX is helping customers with solutions for business problems from proofs of concept through execution. The Company is currently piloting blockchain solutions for supply chain management and improvement as well as other areas. BLOX is actively targeting partnerships and strategic acquisitions of growth companies.

ON BEHALF OF THE BOARD

Jeff Zanini

CEO and Director

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Forward-Looking Information

This news release includes forward-looking information within the meaning of Canadian securities legislation concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company, including future plans for development of technologies by the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Click here to connect with Blox Labs Inc. (CSE:BLOX,FWB:BR1B) for an Investor Presentation. 

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced the Company will have senior management participating in the following virtual financial community conferences and events during December 2020 .

  • Roth Deer Valley Consumer Conference – December 9 th to 11 th , 2020
  • Cantor Fitzgerald 2020 Virtual Cannabis MSO Summit – December 15 th to 16 th , 2020
  • MKM Partners – The Road Ahead, Preparation for 2021 Conference – December 15 th to 16 th , 2020

For more information regarding upcoming Curaleaf financial community conference and event participation please visit the investor relations section of the company website, under the events tab, at https://ir.curaleaf.com/events .

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less